chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Violently vomiting, extreme nausea and abdominal pain.  After years of bloodwork, xrays, gall bladder removed.  Didn't help.  Now diagnosed with gastroparesis.  Had a pacemaker put in stomach March 2013.  Had to stop going to college because she is sick every 2 weeks and in and out of hospital.  Can work maybe 1-2 times a week.  Had to move home and now is on depression medication too.  My daughter was a very healthy happy outgoing child with big dreams.  She is now nothing like she was before the shots.  We are christians living in hell.
Patient had a few days of pain in the left deltoid with shoulder abduction but no redness, warmth, or swelling in the few days after receiving Tdap vaccine 6/21/06, as expected. This resolved and he had been fine until 7/9/06 (18 days after vaccination) when the pain recurred with swelling over the deltoid. No history of trauma or overuse. No itching, redness, or warmth. On exam the next day I noted 2 cm of blanching erythema over the left deltoid with no edema and no subcutaneous or intramuscular mass, no tenderness. This resolved over the next few days. He had Td 6/30/00 (6 years prior).
Immediately after shot - swelling at site of injection site and pain and continued for over 15 min. No dizziness or fainting. No allergies to eggs or latex.
Brief intermittent non-radiating left chest pain. Improved with deep breathing. Patient reported drinking a red bull before appointment. Cardiac and respiratory exam unremarkable. Vitals were all stable. Observed patient for 30 minutes. Patient reported that chest pain had dissipated prior to leaving.
A father reported that his daughter, now 11 years of age, received series of Orimune, Hib-Titer, Tetramune, DTP/DTaP, and MMR II vaccines from May 1991 through 9/21/95. On an unspecified date in 1995, the child was diagnosed with autism. The father stated that he thinks there may be a potential link between her autism and administration of vaccines. Autism was considered medically important (OMIC). This report was received from manufacturer.
About 24 hours after the vaccine, I got very very tired which lasted about a day and subsided on its own. Then on 12/30 my nose got really runny. My husband had tested positive for Covid so I took a test as well an on 12/31 I tested positive to Covid myself. On 1/3 I got Monoclonal Antibiotics but on 1/5 I begin experiencing blood in my trach and lungs, so my PCP advised I go to the ER. At ER a CT scan, ultrasound, and blood work was performed and it was discovered I had Covid Pneumonia in my lower left lobe of my lung. My O2 sat level has been running in the mid-90s.
Pt states, several hours post vax, he had a fever and a headache. On 9/12/01, he had a visit to PMD and states had fast pulse rate and BP was 180/100. Also stated, he had swollen glands in his neck and a headache.
Per patient, symptoms started 2-3 months after completing vaccine series. Started stumbling and having difficulty walking. Now, states she is not able to do anything for herself and completely disabled. States doctors have told her they think it is from COVID-19 vaccine. First Moderna dose administered on 01/18/2021, second dose on 02/22/2021.
The patient received the vaccine at 11:36am.  One to two minutes after injection, she began feeling like her heart was racing and short of breath. She was diaphoretic, had a notable tremor and reported anxiety as well. Patient was transported to the Emergency Department where the patient was monitored.  Ultimately, patient felt better, with a normal EKG.  Patients states this reaction felt similar to anxiety attacks she has had in the past.  ED Physician felt this was likely an anxiety attack.  Patient remained stable throughout ED course and was discharged from the ED in stable condition.
In 1985 and 1986 the patient was vaccinated with an experimental chicken pox vaccine from Germany that had painful injections. In approximately 1995 the patient was vaccinated with two series of varicella virus vaccine live. Subsequently, the patient experienced no immunity to varicella virus vaccine live. Additional information has been requested. This patient also experienced a lack of response while in therapy with measles virus vaccine live, mumps virus vaccine live and rubella virus vaccine live.
Had a purple color to the surrounding skin; Developed multiple blisters in the inner thighs / pus filled; This case was reported by a consumer via call center representative and described the occurrence of blister in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd November 2020, the patient received the 1st dose of Shingrix (intramuscular). In November 2020, between 1 and 2 weeks after receiving Shingrix, the patient experienced blister and skin discoloration. The patient was treated with dermatologicals nos (Calamine Lotion). In November 2020, the outcome of the blister was recovered/resolved. On an unknown date, the outcome of the skin discoloration was unknown.   It was unknown if the reporter considered the blister and skin discoloration to be related to Shingrix.  Additional details were provided as follows: The patient reported for herself. The patient received Shingrix in the deltoid of her right arm and about one week to 10 days after receiving Shingrix, the patient developed multiple blisters in the inner thighs of both the legs, which was pus filled and had a purple color to the surrounding skin. The patient applied Calamine lotion and the blisters resolved in about 2 weeks.  The vaccine lot number was not available. The reporter consented to follow up. This case had been linked with case US2021072883, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021072883:Same reporter. Friend's case.
Patient is a diabetic and currently using insulin pump.  After getting his Pfizer bivalent booster vaccine at 5:00pm he experienced high blood sugar level of 160 at bedtime.  He stated that this high blood sugar event was very unusual for him and the previous night reading was 116.  According to him his wife, also a diabetic, also experienced high blood sugar after her vaccination (I am reporting her event on a separate form).
I kind of started feeling like I was having some allergies and a stuffy nose, but it wasn't that bad. That was starting on the 21st maybe. On the 25th, I woke up and I couldn't really breathe nose was completely clogged; postnasal drip was a lot (really bad) and making my throat sore. The 26th, I woke up feeling even worse. I had a rapid test done at Pharmacy and it came back positive for COVID. Doctor call recommended OTC cold medicine that doesn't contain decongestant, so I have been taking daytime and nighttime Robitussin. I completely lost sense of taste and smell. I do have a heavy chest and the congestion is making it kind of hard to breathe. Pregnancy history: I have been pregnant twice before had one miscarriage and one abortion. Estimated date of delivery for this pregnancy is November 5, 2021.
arm hurt very bad, nausea, chills, 2x4 wheal; took DPH next day 99-100 fever, nausea;
sore arm; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received pneumococcal 13-val conj vac (dipht crm197 protein) (reported as pneumonia vaccine), via an unspecified route of administration on an unspecified date at single dose for immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced sore arm on an unspecified date, without any other problems. The outcome of event was unknown.  Pfizer is a marketing authorization holder of pneumococcal 13-Val Conj Vac (Dipht CRM197 Protein) in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of pneumococcal 13-Val Conj Vac (Dipht CRM197 Protein)] has submitted the same report to the regulatory authorities.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Headache, chills, cold sweats, hot sweats, extreme fatigue, nausea, vomiting in first 48 hours and continued fatigue & brain fog to date
first dose of Shingrix on 23Oct2020 and 2nd dose on 02Dec2020.; This case was reported by a pharmacist and described the occurrence of drug dose administration interval too short in a male patient who received Herpes zoster (Shingrix) (batch number LN399, expiry date 9th October 2022) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 2nd December 2020, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 2nd dose of Shingrix, less than recommended interval which led to shortening of vaccination schedule.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 15-FEB-2016 the patient was vaccinated with an improperly stored dose of PROQUAD (Merck) (lot # L030587, expiration date 10-FEB-2017, dosage and route not specified). It was reported that the vaccine was stored at -13.7 degree Centigrade for 15 hours. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
The same day I had my second dose, I was feeling unwell towards the end of the day. I had a headache and felt nauseous. The following night, I want entire body was full of aches and pains and my head was throbbing. I could not sleep. This led on all the following next day after my second dose. The third day I had massive headache and only slight body aches.
Pt was given Varicella vaccine 09/09/1997, presented to our office 12/04/02 with chicken pox, Fever 102 and headaches for 2 days. Rash was over whole body.
4am I developed a rash and itchiness around injection site on right arm At 7:20pm it?s still red and itchy  I?m going to take a Benadryl 25 mg
Information has been received from a nurse concerning an 18 year old female who on 09-MAY-2007 was vaccinated with the first dose of Gardasil (Lot # 657621/0387U). On 09-MAY-2007 the patient fainted after receiving the first dose of Gardasil. On 09-May-2007, the patient was apprehansive about getting a shot and she had two freinds with her for support. The patient received the injection and did fine, she sat in the exam room, then went out to the waiting room to wait 20 minutes with her freinds. The receptionist called for the nurse as the patient felt faint. The patient appeared pale and fainted while sitting in chair. A cold wet towel was placed on the patient's face and the patient woke up. The patient was taken back to an exam room and laid down. Her vital signs were taken and blood pressue was 80/40 and then 100/64. The patient was given pretzels and fluid. The nurse reported that the patient had not eaten that am. Subsequently on 09-May-2007, the patient recovered from fainting. Unspecified medical attention was sought. No additional information was provided. Additional information has been requested. Additional information is not expected.
Pt received Dose 1 of Pfizer Covid-19 vaccine on Thursday 8-19-21. On Friday 8-20-21 he presented to the ALCH ED with fever, chest pain, vomiting, diarrhea, URI symptoms, elevated troponin and BNP. Echocardiogram revealed pericarditis, EKG showed classic signs of pericarditis with diffuse elevated ST segments. PT was treated inpatient with toradol and ibuprofen for pain, supportive management of obstructive sleep apnea. When BNP and troponin trended into normal limits and repeat Echo showed no increasing pericarditis or worsening cardiac process patient was discharged with follow up scheduled.
Day of vax had whelps on face & back & bathed & alcohol applied-next evening cont to scratch & taken to ER;
fever of 100F; usual side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (usual side effects) and PYREXIA (fever of 100F) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032F21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (EL3247, First dose) on 15-Jan-2021, Pfizer (EL9264 and Second dose) on 07-Feb-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Nov-2021, the patient experienced VACCINATION COMPLICATION (usual side effects). On 04-Nov-2021, the patient experienced PYREXIA (fever of 100F). At the time of the report, VACCINATION COMPLICATION (usual side effects) and PYREXIA (fever of 100F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Nov-2021, Body temperature: 100f (High) fever of 100F..         No concomitant medication was provided.            No treatment information was provided
First blotchy rash, then next day solid red rash from injection site to right above elbow. Itches.
Diagnosed with  unexpected coronary artery disease requiring 5-vessel CABG on 07/03/2021. Minimal classic risk factors: age & gender only. Non-smoker, no diabetes, last total cholesterol 172 in March 2021, SBP ~ 130?s-140?s.
Fire Engineer came to clinic for vaccine for PPD, and Flu vaccine. After vaccine administration outside of clinic EE became lightheaded, and was eased to ground by follow employee. Per employee said EE said he felt woozy, and LOC unknown how long. EE was awake and pale when clinic nurse RN went to EE at front of clinic. EE noted to be pale, diaphoretic, and asking to throw up. Ice pack placed on patient for cooling procedures.  Emesis of morning breakfast,  of trail mix and two large cups of coffee.  Nurse called for additional help from staff and EE intial vital sign 106/66 p50, SaO2 99. EE placed in wheel chair and placed into clinic area. Fire Staff notified Chief Supervisor on duty of situation.  1115 am vitals 94/ 62 p 52 SaO2 96 after two minutes room air 99. Per EE normal pulse is 55 blood sugar 100 by figer stick. EE denied any medical history of DM. HTN or any conditions. Did state has been on shift for 40 days.  Peer notified Chief Supervisor and notified EE of alternates of care.
DAY FOLLOWING INJECT PT COMPLAINED OF ARM ACHING AND BEING HARD AND RED.  DR CONFIRMED SYMPTOMS.
This spontaneous report as received from a pharmacist refers to a 65 year old female patient. The patient was not pregnant. On 02-SEP-2014 the patient was vaccinated with a expired dose of PNEUMOVAX 23 (lot # J006242, expiration date 03-AUG-2014 dose 0.5 ml, frequency was unknown) in the arm which was expired. Concomitant therapies included FLUVIRON. The patient did not seek for medical attention. The patient did not mention experiencing any side effects or follow up with the pharmacy at the time of reporting. This adverse event will be forwarded to the Medical Team for examination. Additional information has been requested.
vaccine was expired, no temperature excursion occurred and moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration".  Patient reports on adverse reaction.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  The reporter reported that because their facility had not been able to download the digital data logger, they had been put on hold at the moment and cannot administer the Moderna COVID-19 vaccine to patients until an assessment was made. There had been no power outages that would have impacted the Moderna vaccine. However, the reporter reiterated that because the facility was unable to download the digital data logger, this issue was treated as a temperature excursion. The reporter was unable to download the data logger for the months of December 2021, January 2022 and February 2022. The reporter was filling out a temperature excursion assessment with the State.   The reporter mentioned that the patient had been administered dose while the temperature excursion assessment was ongoing. The reporter also reported that, no adverse reactions were reported by the patient.  No treatment information was provided by the reporter.
No adverse event noted. Administered expired vaccine. Vaccine expired 04/1/2022. Administered 04/19/2022.
4 days after being given the Moderna vaccine (Feb 6th),  I had extensive racing of my heart that made me feel faint. It lasted a good 6 hrs. Next day (feb 7th), I had the same issue three different times during the day.  Third day, ( Feb 8th) same racing of the heart in the morning.   I then called the cardiologist, and he had me come in the next day, (Feb 9th).  He took my blood pressure three different times and it registered over 160 /SYS.      I have had blood work, nuclear stress test, ECHO and wearing a heart monitor for a month.  All are normal.  In all my years, I have never had racing of the heart or any blood pressure problems.    I am a very health woman.   I have had no more of these events (racing of the heart and high blood pressure ) since February 10th.   Coincidence?????    I don?t think so.   Now I am scheduled for the second Moderna vaccine on March 1, 2021.
Headache, Myalgia, Arthralgia, Nausea Vomiting, INECTION SITE PAIN, SWOLLEN GLANDS
Patient has swollen area appearing to be cellulitis from vaccine. Area approximately 4 inches wide by 3 inches long. Area has gotten bigger over the last 24 hours.
Fever, headache, tiredness, nausea, pain at injection site. Symptoms except injection site pain lasted a day and a half.  Injection site is still sore 2 days after shot.
several pts have recvd 2 vax & had abn hepatic function tests & hematologic changes;
Husband experienced tiredness after vaccination; This spontaneous case was reported by a patient family member or friend and describes the occurrence of FATIGUE (Husband experienced tiredness after vaccination) in a male patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. Unknown) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Husband experienced tiredness after vaccination). At the time of the report, FATIGUE (Husband experienced tiredness after vaccination) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       The concomitant medication was not reported by reporter. The treatment medication was not reported by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-654032, US-MODERNATX, INC.-MOD-2022-654173, US-MODERNATX, INC.-MOD-2022-654068, US-MODERNATX, INC.-MOD-2022-654088, US-MODERNATX, INC.-MOD-2022-654100 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-654032:Same reporter US-MODERNATX, INC.-MOD-2022-654173:Same reporter US-MODERNATX, INC.-MOD-2022-654068:Same reporter US-MODERNATX, INC.-MOD-2022-654088:Same reporter US-MODERNATX, INC.-MOD-2022-654100:Same reporter
Pt reports fatigue, nausea on day 8, body acheson day 9, and rash on calf 28 days after vaccine administration Narrative:
Fever, throbbing headache - both lasting about 2.5 days.  Treatment was rest and tylenol
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown age and gender. No concurrent conditions, medical history and concomitant medications were reported. Approximately in 2016 (reported as from 24-MAR-2016 to 01-APR-2016) multiple unspecified patients were vaccinated with improperly stored GARDASIL 9 lot # L043213, expiry: 28-AUG-2017 (dosing details and route of administration were not reported). The patients sought medical attention. It was reported that the vaccines were exposed to maximum temperature of 9.9C and minimum temperature of 0.8C during at time frame of 2 hours. No previous temperature excursion was reported. No adverse effect was reported. There were no product quality complaint (PQC) involved. This is one of several reports received from the same reporter. Additional information has been requested.
Allergic Reaction; This case was reported by a physician via call center representative and described the occurrence of allergic reaction in a patient who received Flu Seasonal QIV Quebec (FluLaval Tetra 2013-2014) for prophylaxis.   Co-suspect products included flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received FluLaval Tetra 2013-2014 and Flulaval Tetra Pre-Filled Syringe Device. On an unknown date, less than a year after receiving FluLaval Tetra 2013-2014 and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced allergic reaction. On an unknown date, the outcome of the allergic reaction was unknown.   It was unknown if the reporter considered the allergic reaction to be related to FluLaval Tetra 2013-2014 and Flulaval Tetra Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. The physician reported that she had patient who had an allergic reaction to FluLaval vaccine in 2013. The reporter consented to follow up.
My mouth felt like my mouth was burning and dry, tongue fells like its tongue. Went to first doctor appointment on 04/05/2021 where I was given doxycycline. Referred to EMT.  Still having the same issue. Was diagnosed as burning mouth syndrome.